XLV vs TMED
YTDYear to date
XLV wins+7.3 pts
Past year
XLV wins+10.5 pts
Fee
XLV winslower fee
Yield
XLV wins+0.9 pts
AUM
XLV1440.0× more
4–0XLV wins
XLV and TMED · year-to-date · as of Nov 6, 2026 · AUM not scored
TMED vs XLV
YTD$33.77 · −4.5% last sessionDividend-adjusted total return. S&P 500 uses VOO.CompareXLV+ S&P 500+ Peer avg+ Add a fund
Return1D1M3MYTD ▼1Y3Y5YMAX
Total return−4.5%+1.7%−3.2%+13.6%+19.1%——+35.1%
Peer average−3.4%+4.6%+3.5%+19.7%+29.0%+75.3%+27.3%—
S&P 500 · VOO−4.4%−5.7%−4.9%+8.4%+9.8%+82.2%+71.6%+790.6%
T. Rowe Price TMED and XLV · total return, dividends in · as of Nov 6, 2026
TMED’s Holdings
TodayLLY.TOEli Lilly +6.0%UNH.BA5.1%PODD4.1%ALNY3.5%TMO.TO3.4%GILD.TO3.2%ISRG3.2%A3.0%ELAN2.9%COR2.5%DHR2.4%ASND2.4%DXCM2.2%WST2.2%CYTK2.2%PCVX2.2%WAT2.1%DNLI1.9%DYN1.8%IDXX1.8%BSX1.7%ABT1.6%Other
BiotechnologyMedical - DiagnosticsDrug Manufacturers - GeneralMedical - DevicesMedical - Healthcare PlansMedical - InstrumentsOther
T. Rowe Price TMED · 98 holdings · tile size = share of the fund · as of Nov 5, 2026
All 39 Health Care ETFs
YTD| # | Trend | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDRReadDesk | 0.08% | 1.4% | +20.9% | +20.9% | $50.9B | |
| 2 | VHT | Health CareReadDesk | 0.09% | 1.4% | +19.7% | +19.7% | $19.1B | |
| 3 | XBI | State Street SPDR S&P BiotechReadDesk | 0.35% | 0.4% | +21.8% | +21.8% | $10.9B | |
| 4 | IYH | U.S. HealthcareReadDesk | 0.37% | 1.0% | +20.3% | +20.3% | $4.7B | |
| 5 | IXJ | Global HealthcareReadDesk | 0.38% | 1.2% | +19.7% | +19.7% | $4.6B | |
| 6 | IHI | U.S. Medical DevicesReadDesk | 0.37% | 0.4% | −2.7% | −2.7% | $4.1B | |
| 7 | FHLC | Fidelity MSCI Health CareReadDesk | 0.08% | 1.2% | +20.0% | +20.0% | $4.0B | |
| 8 | ARKG | ARK Genomic RevolutionReadDesk | 0.75% | — | +54.0% | +54.0% | $2.2B | |
| 9 | IHE | U.S. PharmaceuticalsReadDesk | 0.37% | 1.4% | +25.6% | +25.6% | $1.6B | |
| 10 | IHF | U.S. Healthcare ProvidersReadDesk | 0.37% | 0.9% | +24.9% | +24.9% | $1.5B | |
| 11 | PBPH | Portfolio Building Block World Pharma and BiotechReadDesk | 0.13% | 0.1% | +22.8% | +22.8% | $1.2B | |
| 12 | FXH | First Trust Health Care AlphaDEXReadDesk | 0.61% | 0.5% | +22.1% | +22.1% | $1.2B | |
| 13 | FTXH | First Trust Nasdaq PharmaceuticalsReadDesk | 0.60% | 0.7% | +31.5% | +31.5% | $1.2B | |
| 14 | PPH | VanEck PharmaceuticalReadDesk | 0.36% | 1.8% | +17.4% | +17.4% | $1.1B | |
| 15 | PJP | PharmaceuticalsReadDesk | 0.58% | 0.9% | +21.9% | +21.9% | $598M | |
| 16 | BBH | VanEck BiotechReadDesk | 0.35% | 0.4% | +32.6% | +32.6% | $519M |
1–16 of 39Page 1 of 3
Health Care · current AUM · as of Nov 6, 2026
TMED Payouts by Year
1YLatest payout, Dec 2025
$0.16
a share
0.5% yield
0.5% yield
1 years added up
$0.16 a share
$0.16 a share
T. Rowe Price TMED · per-share distributions by ex-date · 2025–2025
TMED’s Peers
YTD| # | Trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDR ETFReadVersus | 0.08% | 1.4% | −2.5% | +20.9% | +29.6% | $50.9B | |
| 2 | VHT | Vanguard Health Care ETFReadVersus | 0.09% | 1.4% | −2.9% | +19.7% | +28.0% | $19.1B | |
| 3 | XBI | State Street SPDR S&P Biotech ETFReadVersus | 0.35% | 0.4% | −6.7% | +21.8% | +37.9% | $10.9B | |
| 4 | IYH | iShares U.S. Healthcare ETFReadVersus | 0.37% | 1.0% | −2.8% | +20.3% | +28.8% | $4.7B | |
| 5 | IXJ | iShares Global Healthcare ETFReadVersus | 0.38% | 1.2% | +3.2% | +19.7% | +28.6% | $4.6B | |
| 6 | TMED | T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETFThis fund | 0.44% | 0.5% | −4.5% | +13.6% | +19.1% | $35.4M |
#22 of 33 this year · #20 cheapest of 39 · sorted by assetsOpen the Sectors table →
TMED and its peer group · total return · as of Nov 6, 2026
Cards for This View
TMED’s Top 10 Holdings
Today36.9%of TMED sits in these 10
6GILD.TGilead Sciences 0013.20%
T. Rowe Price TMED · weight in the fund · as of Nov 5, 2026
TMED’s Holdings
TodayLLY.TOEli Lilly +6.0%UNH.BA5.1%PODD4.1%ALNY3.5%TMO.TO3.4%GILD.TO3.2%ISRG3.2%A3.0%ELAN2.9%COR2.5%DHR2.4%ASND2.4%DXCM2.2%WST2.2%CYTK2.2%PCVX2.2%WAT2.1%DNLI1.9%DYN1.8%IDXX1.8%BSX1.7%ABT1.6%Other
BiotechnologyMedical - DiagnosticsDrug Manufacturers - GeneralMedical - DevicesMedical - Healthcare PlansMedical - InstrumentsOther
T. Rowe Price TMED · 98 holdings · tile size = share of the fund · as of Nov 5, 2026
TMED vs Peer Average
YTDTMEDAvsBPeer average
1D−4.5%−3.4%
1M+1.7%+4.6%
3M−3.2%+3.5%
YTD+13.6%+19.7%
1Y+19.1%+29.0%
3Y[…]+75.3%
5Y[…]+27.3%
0–5Peer average wins
38 Health care peers · each row scaled to its leader